Moderna’s Covid-19 vaccine worked safely in children 6 months to 5 years, says the company, which plans to ask health regulators to clear the shot’s use in kids who haven’t been able to get vaccinated
Moderna Inc.’s Covid-19 vaccine safely induced robust immune responses in children ages 6 months to 5 years in a new study, the company said, though the shot had modest efficacy against the Omicron variant.
Moderna said Wednesday the vaccine’s efficacy against symptomatic infections was 43.7% in children ages 6 months to 2 years, and 37.5% in children ages 2 to 5.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Johnson & Johnson COVID-19 Vaccine Shows Promising Long-Term DurabilityEvidence suggests the J&J shot might have an edge in durability over Pfizer’s and Moderna’s vaccines.
Les mer »
Utah’s weekend COVID-19 case count includes lowest single-day tally in 2 yearsCOVID-19 hospitalization rates have fallen since Friday, the Utah Department of Health reported.
Les mer »
State superintendent talks combating learning loss after 2 years of COVID-19Students who started kindergarten in 2020 have now had over two years of disrupted learning.
Les mer »
Exactly 2 years after Utah’s first COVID-19 death, 38 more deaths are reportedExactly two years after Utah announced its first COVID-19 fatality, the state health department reported 38 more deaths — 31 of which occurred before Feb. 22.
Les mer »
UW Medicine: 1 in 4 new COVID-19 cases attributed to BA.2 omicron variantOne in four new COVID-19 cases sequenced at UW Medicine’s virology lab is from the omicron BA.2 subvariant. FOX13
Les mer »